Paradoxical reaction to fluoxetine.
Muhammad N
MN
Momen
C Simon
CS
Sebastian
Peter F
PF
Buckley
D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D003866:Depressive Disorder / Q000097:blood / Q000188:drug therapy*; D005260:Female; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005473:Fluoxetine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications*; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000097:blood / Q000139:chemically induced*; D012307:Risk Factors; D012701:Serotonin / Q000097:blood; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000097:blood / Q000139:chemically induced*
D018687:Antidepressive Agents, Second-Generation; D005338:Fibrin Fibrinogen Degradation Products; D005473:Fluoxetine; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; C036309:fibrin fragment D